The Journey of Cancer Cells to the Brain: Challenges and Opportunities.
Marzena LazarczykMichel Edwar MickaelDominik S SkibaEwa KurzejamskaMichał ŁawińskiJarosław Olav HorbańczukJakub RadziszewskiKarolina FraczekRenata WolinskaJustyna PaszkiewiczPiotr ReligaMariusz SacharczukPublished in: International journal of molecular sciences (2023)
Cancer metastases into the brain constitute one of the most severe, but not uncommon, manifestations of cancer progression. Several factors control how cancer cells interact with the brain to establish metastasis. These factors include mediators of signaling pathways participating in migration, infiltration of the blood-brain barrier, interaction with host cells (e.g., neurons, astrocytes), and the immune system. Development of novel therapies offers a glimpse of hope for increasing the diminutive life expectancy currently forecasted for patients suffering from brain metastasis. However, applying these treatment strategies has not been sufficiently effective. Therefore, there is a need for a better understanding of the metastasis process to uncover novel therapeutic targets. In this review, we follow the journey of various cancer cells from their primary location through the diverse processes that they undergo to colonize the brain. These processes include EMT, intravasation, extravasation, and infiltration of the blood-brain barrier, ending up with colonization and angiogenesis. In each phase, we focus on the pathways engaging molecules that potentially could be drug target candidates.
Keyphrases
- resting state
- white matter
- papillary thyroid
- functional connectivity
- cerebral ischemia
- squamous cell
- end stage renal disease
- emergency department
- epithelial mesenchymal transition
- newly diagnosed
- spinal cord
- chronic kidney disease
- squamous cell carcinoma
- lymph node metastasis
- multiple sclerosis
- spinal cord injury
- blood brain barrier
- subarachnoid hemorrhage
- adverse drug